Provided by Tiger Trade Technology Pte. Ltd.

Acurx Pharmaceuticals, LLC*

1.41
-0.0200-1.40%
Pre-market: 1.410.00000.00%07:00 EDT
Volume:32.57K
Turnover:46.35K
Market Cap:7.71M
PE:-0.46
High:1.43
Open:1.41
Low:1.41
Close:1.43
52wk High:8.34
52wk Low:1.31
Shares:5.47M
Float Shares:5.34M
Volume Ratio:0.43
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0454
EPS(LYR):-5.3153
ROE:-128.11%
ROA:-55.92%
PB:0.95
PE(LYR):-0.27

Loading ...

Acurx Pharmaceuticals - Files for Resale of 1,500,000 Common Shares - SEC Filing

THOMSON REUTERS
·
Yesterday

Acurx Pharma Announces Annual Shareholder Meeting

Reuters
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 20

Acurx Pharmaceuticals Receives FDA Conditional Acceptance and Uspto Trademark Allowance for the Company's Brand Name for Ibezapolstat

THOMSON REUTERS
·
Aug 17

Analysts Are Bullish on Top Healthcare Stocks: Candel Therapeutics (CADL), Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 14

Acurx Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Acurx Pharmaceuticals Q2 EPS $(0.53) Misses $(0.37) Estimate

Benzinga Earnings
·
Aug 14

Acurx Pharmaceuticals Q2 EPS USD -0.53

THOMSON REUTERS
·
Aug 14

Press Release: Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 Results and Provides Business Update

Dow Jones
·
Aug 14

Acurx Net Loss Flat at $2.26 Million in Q2 2026

Reuters
·
Aug 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

ACXP Advances Ibezapolstat Trial in High-Risk C. Difficile Patients

TIPRANKS
·
Aug 13

Acurx Pharmaceuticals Inc Expected to Post a Loss of 38 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Acurx Says Japan, Mexico Patent Offices Grant New Patents for DNA Polymerase IIIC Inhibitor Antibiotics

Reuters
·
Aug 12

Acurx partners with Leiden University Medical Center to develop its antibiotics

TIPRANKS
·
Aug 10

Acurx Partners with Leiden UMC to Develop First 3D Structure of MRSA PolC Bound to Its Antibiotic Inhibitor

Reuters
·
Aug 10

Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase Iiic Inhibitor Antibiotics

THOMSON REUTERS
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 03

Acurx Says FDA Open to Single Phase 3 Trial to Support Ibezapolstat CDI NDA Filing

Reuters
·
Aug 03

Acurx Pharmaceuticals - Receives FDA Guidance on Single Phase 3 Trial Nda for Ibezapolstat in Cdi

THOMSON REUTERS
·
Aug 03